#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gastric cancer Anti-myelin-associated glycoprotein antibodies positive Acute respiratory distress syndrome Vernal keratoconjunctivitis Selective polysaccharide antibody deficiency Chronic myelomonocytic leukaemia Breast angiosarcoma metastatic Albright's disease Transitional cell cancer of the renal pelvis and ureter Squamous cell carcinoma of the oral cavity Medullary thyroid cancer Chronic graft versus host disease Chronic lymphocytic leukaemia recurrent Chronic myeloid leukaemia (in remission) Pleomorphic leiomyosarcoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis Primary mediastinal large B-cell lymphoma – Trials in Disease Adrenogenital syndrome – Trials in Disease Rhabdomyosarcoma – Basic Information Loeys-Dietz syndrome – Diagnostics Alport’s syndrome – Trials in Disease Nephrotic syndrome – Life with Disease Ehlers-Danlos syndrome – Basic Information Von Willebrand’s disease – Diagnostics Nephrotic syndrome More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ziftomenib Brepocitinib Tosilate F770/05 177LU-PSMA-I&T Phenprocoumon Ruxolitinib ARI0008 Efzofitimod Budigalimab Insulin Icodec Ublituximab Clopidogrel Isis 696844 ADX-324 Beclometasone Dipropionate Tapderimotide Risperidone Insulin Glargine Daratumumab Ro7589655 More therapies…

    Learn about Your Condition

    Laryngeal cancer stage III Polymyositis Hyperglycaemia Haemorrhage Menopausal symptoms Lip and/or oral cavity cancer Genitourinary tract neoplasm Oropharyngeal cancer Colon cancer stage II Basal cell naevus syndrome Nasal sinus cancer Tumour thrombosis Arrhythmia supraventricular Bipolar I disorder Vascular dementia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of Doxycycline Bone and Joint Penetration in Patients Undergoing Total Hip Arthroplasty for Hip Osteoarthritis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Doxycycline Monohydrate
    • Doxycycline
    France

  • Safety and Tolerability of PTI5803 in Patients Aged 14 Years and Older With Drug‑Resistant Seizures Due to Focal Cortical Dysplasia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Epilepsy
    France

  • Evaluation of belantamab mafodotin plus drug combination in adult patients with newly diagnosed light chain amyloidosis

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Amyloidosis
    Investigated Drugs:
    • GSK5764227
    • Bortezomib
    • Cyclophosphamide
    Greece Italy Spain

  • Phase 1/2 First‑in‑Human Study of Oral GSK5471713B in Adults with Metastatic Castration‑Resistant Prostate Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Prostate cancer
    France The Netherlands Spain

  • Efficacy and safety of eplontersen sodium plus ALXN2220 in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Alxn2220
    France Germany Italy Spain Sweden

  • Assessing Hemodynamic Effect and Safety of TX000045 in Adults with Pulmonary Hypertension Secondary to Interstitial Lung Disease

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • TX000045
    Poland Romania Spain
Previous Page
1 … 675 676 677 678 679 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!